ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Interleukin-2 for Injection Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-35F11453
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Interleukin 11 for Injection Market Research Report 2022
BUY CHAPTERS

Global Human Interleukin-2 for Injection Market Research Report 2025

Code: QYRE-Auto-35F11453
Report
January 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Clinigen
3SBio Inc
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute of Biological Products
Shandong Quangang Pharmaceutical

Human Interleukin-2 for Injection Market Size

The global market for Human Interleukin-2 for Injection was valued at US$ 46.8 million in the year 2024 and is projected to reach a revised size of US$ 63.4 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Human Interleukin-2 for Injection Market

Human Interleukin-2 for Injection Market

Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body"s immune system.
Human Interleukin-2 (IL-2) is a vital immunoregulatory protein used in the treatment of various cancers and immune-related diseases. The market is substantial and continuously expanding, benefiting from the growing population of cancer patients and the widespread application of immunotherapy. Sales are consistently rising, especially in novel immunotherapy fields like CAR-T cell therapy. Specific uses include the treatment of malignancies such as malignant melanoma, renal cell carcinoma, and advanced metastatic colorectal cancer. The future development prospects are promising, with anticipated approvals for more indications and treatment modalities driving continued market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Interleukin-2 for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Interleukin-2 for Injection.
The Human Interleukin-2 for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Interleukin-2 for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Interleukin-2 for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Interleukin-2 for Injection Market Report

Report Metric Details
Report Name Human Interleukin-2 for Injection Market
Accounted market size in year US$ 46.8 million
Forecasted market size in 2031 US$ 63.4 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 50000 IU
  • 100000 IU
  • 200000 IU
  • 500000 IU
  • 1 Million IU
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biotechnology, Changchun Institute Of Biological Products, Shandong Quangang Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Interleukin-2 for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Interleukin-2 for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Interleukin-2 for Injection Market growing?

Ans: The Human Interleukin-2 for Injection Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Human Interleukin-2 for Injection Market size in 2031?

Ans: The Human Interleukin-2 for Injection Market size in 2031 will be US$ 63.4 million.

Who are the main players in the Human Interleukin-2 for Injection Market report?

Ans: The main players in the Human Interleukin-2 for Injection Market are Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biotechnology, Changchun Institute Of Biological Products, Shandong Quangang Pharmaceutical

What are the Application segmentation covered in the Human Interleukin-2 for Injection Market report?

Ans: The Applications covered in the Human Interleukin-2 for Injection Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Human Interleukin-2 for Injection Market report?

Ans: The Types covered in the Human Interleukin-2 for Injection Market report are 50000 IU, 100000 IU, 200000 IU, 500000 IU, 1 Million IU

Recommended Reports

Therapeutics & Biologics

Oncology & Immunotherapy

Injection & Drug Delivery

1 Human Interleukin-2 for Injection Market Overview
1.1 Product Definition
1.2 Human Interleukin-2 for Injection by Type
1.2.1 Global Human Interleukin-2 for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 50000 IU
1.2.3 100000 IU
1.2.4 200000 IU
1.2.5 500000 IU
1.2.6 1 Million IU
1.3 Human Interleukin-2 for Injection by Application
1.3.1 Global Human Interleukin-2 for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Human Interleukin-2 for Injection Market Size Estimates and Forecasts
1.4.1 Global Human Interleukin-2 for Injection Revenue 2020-2031
1.4.2 Global Human Interleukin-2 for Injection Sales 2020-2031
1.4.3 Global Human Interleukin-2 for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Interleukin-2 for Injection Market Competition by Manufacturers
2.1 Global Human Interleukin-2 for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Interleukin-2 for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Interleukin-2 for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Interleukin-2 for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Interleukin-2 for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Interleukin-2 for Injection, Product Type & Application
2.7 Global Key Manufacturers of Human Interleukin-2 for Injection, Date of Enter into This Industry
2.8 Global Human Interleukin-2 for Injection Market Competitive Situation and Trends
2.8.1 Global Human Interleukin-2 for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Interleukin-2 for Injection Players Market Share by Revenue
2.8.3 Global Human Interleukin-2 for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Interleukin-2 for Injection Market Scenario by Region
3.1 Global Human Interleukin-2 for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Interleukin-2 for Injection Sales by Region: 2020-2031
3.2.1 Global Human Interleukin-2 for Injection Sales by Region: 2020-2025
3.2.2 Global Human Interleukin-2 for Injection Sales by Region: 2026-2031
3.3 Global Human Interleukin-2 for Injection Revenue by Region: 2020-2031
3.3.1 Global Human Interleukin-2 for Injection Revenue by Region: 2020-2025
3.3.2 Global Human Interleukin-2 for Injection Revenue by Region: 2026-2031
3.4 North America Human Interleukin-2 for Injection Market Facts & Figures by Country
3.4.1 North America Human Interleukin-2 for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Interleukin-2 for Injection Sales by Country (2020-2031)
3.4.3 North America Human Interleukin-2 for Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Interleukin-2 for Injection Market Facts & Figures by Country
3.5.1 Europe Human Interleukin-2 for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Interleukin-2 for Injection Sales by Country (2020-2031)
3.5.3 Europe Human Interleukin-2 for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Interleukin-2 for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Human Interleukin-2 for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Interleukin-2 for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Interleukin-2 for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Interleukin-2 for Injection Market Facts & Figures by Country
3.7.1 Latin America Human Interleukin-2 for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Interleukin-2 for Injection Sales by Country (2020-2031)
3.7.3 Latin America Human Interleukin-2 for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Interleukin-2 for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Interleukin-2 for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Interleukin-2 for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Interleukin-2 for Injection Sales by Type (2020-2031)
4.1.1 Global Human Interleukin-2 for Injection Sales by Type (2020-2025)
4.1.2 Global Human Interleukin-2 for Injection Sales by Type (2026-2031)
4.1.3 Global Human Interleukin-2 for Injection Sales Market Share by Type (2020-2031)
4.2 Global Human Interleukin-2 for Injection Revenue by Type (2020-2031)
4.2.1 Global Human Interleukin-2 for Injection Revenue by Type (2020-2025)
4.2.2 Global Human Interleukin-2 for Injection Revenue by Type (2026-2031)
4.2.3 Global Human Interleukin-2 for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Human Interleukin-2 for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Interleukin-2 for Injection Sales by Application (2020-2031)
5.1.1 Global Human Interleukin-2 for Injection Sales by Application (2020-2025)
5.1.2 Global Human Interleukin-2 for Injection Sales by Application (2026-2031)
5.1.3 Global Human Interleukin-2 for Injection Sales Market Share by Application (2020-2031)
5.2 Global Human Interleukin-2 for Injection Revenue by Application (2020-2031)
5.2.1 Global Human Interleukin-2 for Injection Revenue by Application (2020-2025)
5.2.2 Global Human Interleukin-2 for Injection Revenue by Application (2026-2031)
5.2.3 Global Human Interleukin-2 for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Human Interleukin-2 for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Clinigen
6.1.1 Clinigen Company Information
6.1.2 Clinigen Description and Business Overview
6.1.3 Clinigen Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Clinigen Human Interleukin-2 for Injection Product Portfolio
6.1.5 Clinigen Recent Developments/Updates
6.2 3SBio
6.2.1 3SBio Company Information
6.2.2 3SBio Description and Business Overview
6.2.3 3SBio Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 3SBio Human Interleukin-2 for Injection Product Portfolio
6.2.5 3SBio Recent Developments/Updates
6.3 Beijing Four Rings Biopharmaceutical
6.3.1 Beijing Four Rings Biopharmaceutical Company Information
6.3.2 Beijing Four Rings Biopharmaceutical Description and Business Overview
6.3.3 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Product Portfolio
6.3.5 Beijing Four Rings Biopharmaceutical Recent Developments/Updates
6.4 Jiangsu Kingsley Pharmaceutical
6.4.1 Jiangsu Kingsley Pharmaceutical Company Information
6.4.2 Jiangsu Kingsley Pharmaceutical Description and Business Overview
6.4.3 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Product Portfolio
6.4.5 Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
6.5 Beijing Yuance Pharmaceutical
6.5.1 Beijing Yuance Pharmaceutical Company Information
6.5.2 Beijing Yuance Pharmaceutical Description and Business Overview
6.5.3 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Product Portfolio
6.5.5 Beijing Yuance Pharmaceutical Recent Developments/Updates
6.6 Beijing SL Pharm
6.6.1 Beijing SL Pharm Company Information
6.6.2 Beijing SL Pharm Description and Business Overview
6.6.3 Beijing SL Pharm Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beijing SL Pharm Human Interleukin-2 for Injection Product Portfolio
6.6.5 Beijing SL Pharm Recent Developments/Updates
6.7 Shanghai Huaxin Biotechnology
6.7.1 Shanghai Huaxin Biotechnology Company Information
6.7.2 Shanghai Huaxin Biotechnology Description and Business Overview
6.7.3 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Product Portfolio
6.7.5 Shanghai Huaxin Biotechnology Recent Developments/Updates
6.8 Changchun Institute Of Biological Products
6.8.1 Changchun Institute Of Biological Products Company Information
6.8.2 Changchun Institute Of Biological Products Description and Business Overview
6.8.3 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Product Portfolio
6.8.5 Changchun Institute Of Biological Products Recent Developments/Updates
6.9 Shandong Quangang Pharmaceutical
6.9.1 Shandong Quangang Pharmaceutical Company Information
6.9.2 Shandong Quangang Pharmaceutical Description and Business Overview
6.9.3 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Product Portfolio
6.9.5 Shandong Quangang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Interleukin-2 for Injection Industry Chain Analysis
7.2 Human Interleukin-2 for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Interleukin-2 for Injection Production Mode & Process Analysis
7.4 Human Interleukin-2 for Injection Sales and Marketing
7.4.1 Human Interleukin-2 for Injection Sales Channels
7.4.2 Human Interleukin-2 for Injection Distributors
7.5 Human Interleukin-2 for Injection Customer Analysis
8 Human Interleukin-2 for Injection Market Dynamics
8.1 Human Interleukin-2 for Injection Industry Trends
8.2 Human Interleukin-2 for Injection Market Drivers
8.3 Human Interleukin-2 for Injection Market Challenges
8.4 Human Interleukin-2 for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Clinigen
3SBio Inc
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute of Biological Products
Shandong Quangang Pharmaceutical
List of Tables
 Table 1. Global Human Interleukin-2 for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Interleukin-2 for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Interleukin-2 for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Interleukin-2 for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Interleukin-2 for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Interleukin-2 for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Interleukin-2 for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Interleukin-2 for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Interleukin-2 for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Interleukin-2 for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Interleukin-2 for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Human Interleukin-2 for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Interleukin-2 for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Interleukin-2 for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Interleukin-2 for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Interleukin-2 for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Interleukin-2 for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Human Interleukin-2 for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Interleukin-2 for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Human Interleukin-2 for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Interleukin-2 for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Interleukin-2 for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Interleukin-2 for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Interleukin-2 for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Interleukin-2 for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Interleukin-2 for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Interleukin-2 for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Interleukin-2 for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Interleukin-2 for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Interleukin-2 for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Interleukin-2 for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Interleukin-2 for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Interleukin-2 for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Interleukin-2 for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Interleukin-2 for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Interleukin-2 for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Interleukin-2 for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Interleukin-2 for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Interleukin-2 for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Interleukin-2 for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Interleukin-2 for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Interleukin-2 for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Interleukin-2 for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Interleukin-2 for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Interleukin-2 for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Interleukin-2 for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Interleukin-2 for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Interleukin-2 for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Interleukin-2 for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Human Interleukin-2 for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Human Interleukin-2 for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Interleukin-2 for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Interleukin-2 for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Interleukin-2 for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Interleukin-2 for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Interleukin-2 for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Interleukin-2 for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Interleukin-2 for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Interleukin-2 for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Human Interleukin-2 for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Human Interleukin-2 for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Interleukin-2 for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Interleukin-2 for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Interleukin-2 for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Interleukin-2 for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Interleukin-2 for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Clinigen Company Information
 Table 71. Clinigen Description and Business Overview
 Table 72. Clinigen Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Clinigen Human Interleukin-2 for Injection Product
 Table 74. Clinigen Recent Developments/Updates
 Table 75. 3SBio Company Information
 Table 76. 3SBio Description and Business Overview
 Table 77. 3SBio Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. 3SBio Human Interleukin-2 for Injection Product
 Table 79. 3SBio Recent Developments/Updates
 Table 80. Beijing Four Rings Biopharmaceutical Company Information
 Table 81. Beijing Four Rings Biopharmaceutical Description and Business Overview
 Table 82. Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Product
 Table 84. Beijing Four Rings Biopharmaceutical Recent Developments/Updates
 Table 85. Jiangsu Kingsley Pharmaceutical Company Information
 Table 86. Jiangsu Kingsley Pharmaceutical Description and Business Overview
 Table 87. Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Product
 Table 89. Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
 Table 90. Beijing Yuance Pharmaceutical Company Information
 Table 91. Beijing Yuance Pharmaceutical Description and Business Overview
 Table 92. Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Product
 Table 94. Beijing Yuance Pharmaceutical Recent Developments/Updates
 Table 95. Beijing SL Pharm Company Information
 Table 96. Beijing SL Pharm Description and Business Overview
 Table 97. Beijing SL Pharm Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Beijing SL Pharm Human Interleukin-2 for Injection Product
 Table 99. Beijing SL Pharm Recent Developments/Updates
 Table 100. Shanghai Huaxin Biotechnology Company Information
 Table 101. Shanghai Huaxin Biotechnology Description and Business Overview
 Table 102. Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Product
 Table 104. Shanghai Huaxin Biotechnology Recent Developments/Updates
 Table 105. Changchun Institute Of Biological Products Company Information
 Table 106. Changchun Institute Of Biological Products Description and Business Overview
 Table 107. Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Changchun Institute Of Biological Products Human Interleukin-2 for Injection Product
 Table 109. Changchun Institute Of Biological Products Recent Developments/Updates
 Table 110. Shandong Quangang Pharmaceutical Company Information
 Table 111. Shandong Quangang Pharmaceutical Description and Business Overview
 Table 112. Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Product
 Table 114. Shandong Quangang Pharmaceutical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Human Interleukin-2 for Injection Distributors List
 Table 118. Human Interleukin-2 for Injection Customers List
 Table 119. Human Interleukin-2 for Injection Market Trends
 Table 120. Human Interleukin-2 for Injection Market Drivers
 Table 121. Human Interleukin-2 for Injection Market Challenges
 Table 122. Human Interleukin-2 for Injection Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Interleukin-2 for Injection
 Figure 2. Global Human Interleukin-2 for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Interleukin-2 for Injection Market Share by Type: 2024 & 2031
 Figure 4. 50000 IU Product Picture
 Figure 5. 100000 IU Product Picture
 Figure 6. 200000 IU Product Picture
 Figure 7. 500000 IU Product Picture
 Figure 8. 1 Million IU Product Picture
 Figure 9. Global Human Interleukin-2 for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Human Interleukin-2 for Injection Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Pharmacy
 Figure 13. Global Human Interleukin-2 for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Human Interleukin-2 for Injection Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Human Interleukin-2 for Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Human Interleukin-2 for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 17. Human Interleukin-2 for Injection Report Years Considered
 Figure 18. Human Interleukin-2 for Injection Sales Share by Manufacturers in 2024
 Figure 19. Global Human Interleukin-2 for Injection Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Human Interleukin-2 for Injection Players: Market Share by Revenue in Human Interleukin-2 for Injection in 2024
 Figure 21. Human Interleukin-2 for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Human Interleukin-2 for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Human Interleukin-2 for Injection Sales Market Share by Country (2020-2031)
 Figure 24. North America Human Interleukin-2 for Injection Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Human Interleukin-2 for Injection Sales Market Share by Country (2020-2031)
 Figure 28. Europe Human Interleukin-2 for Injection Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Human Interleukin-2 for Injection Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Human Interleukin-2 for Injection Revenue Market Share by Region (2020-2031)
 Figure 36. China Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Human Interleukin-2 for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Human Interleukin-2 for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Human Interleukin-2 for Injection Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Human Interleukin-2 for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Human Interleukin-2 for Injection by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Human Interleukin-2 for Injection by Type (2020-2031)
 Figure 58. Global Human Interleukin-2 for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Human Interleukin-2 for Injection by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Human Interleukin-2 for Injection by Application (2020-2031)
 Figure 61. Global Human Interleukin-2 for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 62. Human Interleukin-2 for Injection Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Injection Human Interleukin 2 Market Research Report 2025
Global Recombinant Human Interleukin 2 Injection Market Research Report 2024
Global Interleukin Market Research Report 2025
Global Recombinant Human Interleukin Market Insights Forecast to 2030
Global Cytokines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Innovations in Biologics and Biosimilars Market Research Report 2024
Global Infliximab Injection Market Research Report 2024
Global Biologics and Biosimilars Market Research Report 2025
Proleukin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Global Human Interleukin 2 IL 2 Market Research Report 2024
Global Bovine Interleukin 2 IL2 ELISA Kit Market Research Report 2024
Global Interleukin 2 ELISA Kit Market Research Report 2024
Global Interferon Injection Market Research Report 2024
Global Long acting Interferon Injection Market Research Report 2024
Global Short acting Interferon Injection Market Research Report 2024
Global Cytokines as Cell Culture Supplements Market Research Report 2024
Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global CD25 IL2R alpha Antibody Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions